ArticleJournal for immunotherapy of cancer2021

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.

Xu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.